Clinically Meaningful Tumor Reduction Rates Vary by Prechemotherapy MRI Phenotype and Tumor Subtype in the I-SPY 1 TRIAL (CALGB 150007/150012; ACRIN 6657)
      QxMD      Google Scholar   
Citation:
Ann Surg Oncol vol 20 (12) 3823-3830
Year:
2013
Type:
Manuscript
Funding:
NCTN
Endpoint:
Secondary
Analysis:
Primary
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
epub
Note:
Methodological:
No
Biospecimen:
No
SDC:
No
Book Volume:
Parents:
673  
Children:
None
Program:
OGC
Primary Committee:
Breast
Sec. Committees:
   
Pharmas:
 
Grants:
CA33601, CA58207, U01 CA080098, U10 CA031946, U10 CA033601, U10 CA079778, P50 CA058207, U01 CA079778, U10 CA080098, CA31946  
Corr. Author:
 
Authors:
             
Networks:
 
Study
CALGB-150007
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:
N/A
Keywords:
Breast Oncology